Saturates the skins surface with intense moisturisers and nourishing, personalised ingredients
nerwowym i hormonalnym co moe skutkowa rnorodnymi (czsto niepodanymi) efektami oglnoustrojowymi
Built on science, its products have clinical backing for their impact on digestion and metabolic health, including weight loss and diabetes management
However, too much nitric oxide in the body leads to inflammation and chronic diseases
(2022) demonstrated Cerebrolysin's effects on Alzheimer's disease biomarkers in a randomized controlled trial, providing objective biological evidence for its neurotrophic activity (PMID: 36155516) Regulatory Validation: Approved for clinical use in over 40 countries for indications including stroke, traumatic brain injury, and dementia (though not FDA-approved in the United States) Dihexa: Preclinical Only, with Integrity Concerns Dihexa's evidence base is entirely preclinical and has faced significant scientific integrity challenges: Foundational Research: Wright et al
The combination of these two medicines has led to significant weight loss and improved glycemic control in adults with obesity or overweight during clinical trials
